trending Market Intelligence /marketintelligence/en/news-insights/trending/Bt1Qf-dMQLVyTWLV0J05Cg2 content esgSubNav
In This List

GlycoMimetics appoints director

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management


GlycoMimetics appoints director

GlycoMimetics Inc. appointed Patricia Andrews to its board of directors.

Andrews is CEO and director of privately held Boston Biomedical Inc.